血管老化駆動性勃起不全:病態生理学的メカニズムと新たな治療法に関するナラティブレビュー
Ke Zhong1, Huifang Hu1, Liang Xiao2
1Department of Urology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.
Translational andrology and urology
|January 12, 2026
まとめ
加齢関連勃起不全(ED)は血管老化と関連している。内皮機能、幹細胞、ナノテクノロジーを標的とする新しい治療法は、この血管の健康状態の指標に対する現在の治療法を超えて有望視されている。
科学分野:
- 老年医学
- 血管生物学
- 泌尿器科学
背景:
- 加齢関連勃起不全(ED)は、血管老化と関連した重大な健康問題であり、内皮機能障害と血管平滑筋の変化を特徴とします。
- 高齢男性におけるEDは、全身性血管病理と関連しており、全体的な血管の健康状態の早期警告信号として機能します。
研究 の 目的:
- 高齢男性における加齢関連EDの病態生理学的メカニズムを探求すること。
- 加齢関連EDの診断と新規標的療法の開発に新たな方向性を提供すること。
主な方法:
- 2000年から2025年までの包括的な文献レビューを実施しました。
- PubMed、Web of Science、Embaseで、勃起不全、老化、血管内皮、血管平滑筋に関連するキーワードを使用して検索しました。
- 病態生理学または新規治療法に関する質の高い臨床研究および前臨床研究を優先しました。
主要な成果:
- 加齢関連EDの主な原因には、一酸化窒素の利用能低下、内皮の酸化的ストレス、炎症、平滑筋量の減少、動脈硬化の亢進が含まれます。代謝性疾患、慢性炎症、酸化的ストレス、ホルモンバランスの乱れは血管老化を加速させ、EDは全身性血管病理の早期指標となります。現在のPDE5阻害薬やテストステロンなどの治療法は対症療法を提供しますが、限界があります。新たな介入は実験段階です。
結論:
- 加齢関連EDは、全身性血管病理の現れであり、血管の健康状態の早期警告信号です。
- 現在のED治療法には限界があり、高度な治療戦略の必要性が強調されています。
- 将来有望な方向性には、内皮型一酸化窒素合成酵素機能の強化、幹細胞療法、ED治療のためのナノテクノロジーが含まれます。
関連する概念動画
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
547
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
547
Disorders of the Male Reproductive System
3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
Hypertension II: Pathophysiology
770
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
770
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
Peripheral Artery Disease III: Interprofessional Care
232
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
232


